Mod GRF 1-29 & GHRP-6 Blend (10mg) – Premium Synergistic GH Research Peptide

Welcome to Liaocheng Yixin Company, your trusted source for premium mod grf 1-29 ghrp-6 10mg blend for research. As a specialized peptide synthesis manufacturer operating from our facility at No. 9 Lushan Road, Dongcheng Street, Liaocheng Economic and Technological Development Zone, Shandong Province, we provide high-quality research compounds for the global scientific community. mod grf 1-29 ghrp-6 10mg blend for research

This 10mg blend combines Modified GRF 1-29 (a stabilized GHRH analog also known as CJC-1295 without DAC) with GHRP-6 (a synthetic ghrelin mimetic) to create a powerful research tool that activates complementary receptor pathways in the hypothalamic-pituitary axis. Our mod grf 1-29 ghrp-6 10mg blend for research offers investigators a convenient, pre-mixed formulation for growth hormone axis, tissue repair, and regenerative studies.

What is Mod GRF 1-29 & GHRP-6 Blend?

Modified GRF 1-29 (often referred to as CJC-1295 without DAC) is a tetrasubstituted GHRH analog with four amino acid substitutions at positions 2, 8, 15, and 27 that protect it from rapid enzymatic degradation, extending its half-life to approximately 30 minutes. GHRP-6 is a synthetic hexapeptide that acts as a potent agonist of the growth hormone secretagogue receptor (GHS-R1a), also known as the ghrelin receptor.

Key identifiers:

• Components: Modified GRF 1-29 (5mg) + GHRP-6 (5mg)

• Total Mass: 10mg lyophilized powder

• Molecular Formula (Mod GRF 1-29): C152H252N44O42

• Molecular Formula (GHRP-6): C46H56N12O6

• Molecular Weight (Mod GRF 1-29): 3367.95 g/mol

• Molecular Weight (GHRP-6): 873.03 g/mol

• Sequence (GHRP-6): His-D-Trp-Ala-Trp-D-Phe-Lys-NH2

• Purity: ≥99% verified by HPLC

• mod grf 1-29 ghrp-6 10mg blend for research

Mechanism of Action in Research

The blend combines two distinct pathways to amplify growth hormone release through synergistic action:

Modified GRF 1-29 – GHRH Receptor Pathway

Modified GRF 1-29 binds the GHRH receptor (GHRHR) on anterior pituitary somatotrophs, activating Gs-coupled adenylyl cyclase signaling. This elevates intracellular cAMP, activates protein kinase A (PKA), and phosphorylates CREB to drive GH gene transcription and prime secretory vesicles for exocytosis. Research by Khorram et al. reported that Mod GRF 1-29 supports a 70% to 107% increase in the 12-hour area under the curve of hGH concentrations.

GHRP-6 – GHS-R1a Pathway

GHRP-6 activates the growth hormone secretagogue receptor type 1a (GHS-R1a), the endogenous ghrelin receptor. This triggers Gq-coupled phospholipase C (PLC) signaling, generating IP3 and DAG, mobilizing intracellular calcium, and activating protein kinase C (PKC). The resulting calcium influx directly triggers GH vesicle exocytosis. Research by Frieboes et al. suggests GHRP-6 may induce a nearly threefold increase in growth hormone release compared to control.

Hypothalamic Effects of GHRP-6

GHRP-6 provides additional hypothalamic-level effects: it stimulates endogenous GHRH release from arcuate nucleus neurons and functionally suppresses somatostatin release from periventricular neurons. This dual hypothalamic action creates a permissive environment for maximal GH pulse amplitude.  mod grf 1-29 ghrp-6 10mg blend for research

Synergistic Amplification

The combination of GHRH-pathway (cAMP/PKA) and ghrelin-pathway (PLC/PKC/Ca2+) activation produces synergistic GH release that significantly exceeds the sum of individual peptide effects. Research by Bowers et al. demonstrated that combining GHRH with GHRP-6 produced GH responses 3-10 times greater than either compound alone in human subjects. A landmark study found that a GHS alone may lead to a 47-fold increase in pulsatile hGH secretion, GHRH analogs alone a 20-fold increase, and the combination a 54-fold increase compared to controls.

Scientific Research Applications

Growth Hormone Secretagogue Research

The Mod GRF 1-29 & GHRP-6 blend is used to study the interconnected pathways of GH regulation. Modified GRF 1-29 preserves pulsatile GH secretion during stimulation, a critical distinction from exogenous GH administration. This makes the blend valuable for investigating physiologic GH pulse patterns, which research suggests are more beneficial than continuous GH exposure.

Tissue Repair and Wound Healing Research

GHRP-6 has demonstrated significant wound-healing activity in preclinical models. In cutaneous wound studies, GHRP-6 enhanced the healing process with accelerated re-epithelialization and reduced scarring. Proteomic analysis revealed that GHRP-6 prevents cutaneous hypertrophic scarring through early modulation of extracellular matrix proteins and inflammatory mediators.

Neuroprotection Research

The ghrelin/GHS-R system has demonstrated neuroprotective effects, protecting hippocampal neurogenesis in chronic unpredictable mild stress models with anxiolytic and neurotrophic properties. Preclinical stroke studies have assessed GHRP-6 co-administered with rhEGF, demonstrating neuroprotective and neuroregenerative effects in ischemic brain injury models.

Bone and Growth Research

Elevated GH and IGF-1 from dual-pathway stimulation support osteoblast activity and bone mineral density in preclinical models. The sustained GH pulsatility preserved by Modified GRF 1-29 is particularly relevant for bone anabolism, as physiologic GH pulse patterns are more osteogenic than continuous GH exposure. mod grf 1-29 ghrp-6 10mg blend for research

Metabolic and Body Composition Studies

Clinical studies with GRF 1-29 suggest it may increase nocturnal growth hormone levels, serum IGF-I and IGFBP-3 concentrations, and GHBP concentrations. Male test subjects presented with the peptide for four months reportedly experienced a significant increase in lean body mass by 1.26 kg. GHRP-6 also may have anabolic potential mediated via growth hormone and IGF-1 stimulating action.

Why Choose Liaocheng Yixin Company?

When sourcing mod grf 1-29 ghrp-6 10mg blend for research, quality and reliability are paramount. Here’s why researchers trust us:

Manufacturer-Direct Quality

We are a legitimate, licensed peptide synthesis company with a physical headquarters in Shandong Province, China. Our facility maintains strict quality control standards.

Verified Purity Standards

Every batch undergoes rigorous testing using HPLC analysis. Certificates of Analysis are available upon request.

Research-Grade Specifications

• Purity: ≥99% verified by HPLC

• Appearance: White lyophilized powder

• Storage: Store powder at -20°C in a sealed container, protected from light and moisture

• Form: Lyophilized powder for research use

Quality Assurance & Testing

Every batch undergoes comprehensive quality control:

1. Synthesis by experienced chemists using solid-phase peptide synthesis

2. Purification via preparative HPLC

3. Analysis using HPLC for purity verification

4. Mass Spectrometry for molecular weight confirmation

5. Packaged in sterile conditions for research use

6. mod grf 1-29 ghrp-6 10mg blend for research

Q: How does the Mod GRF 1-29 & GHRP-6 blend work in research?

A: The blend activates two complementary receptor pathways: Modified GRF 1-29 stimulates the GHRH receptor (cAMP/PKA pathway), while GHRP-6 activates the ghrelin receptor (GHS-R1a) via calcium mobilization. This dual pathway activation produces synergistic GH release that significantly exceeds the sum of individual peptide effects. Research demonstrates GHRP-6 raises the basal set-point of GH secretion while Modified GRF 1-29 drives pulsatile GH release from this elevated baseline.

Q: What are the key research applications for this blend?

A: The blend is used in growth hormone secretagogue research, tissue repair and wound healing studies, neuroprotection research, bone and growth studies, metabolic and body composition investigations, and aging research.

Q: Does this blend affect other hormones?

A: GHRP-6 may cause dose-dependent increases in appetite (a direct ghrelin-pathway effect) and transient cortisol and prolactin elevation. Unlike ipamorelin, GHRP-6 has a stronger appetite-stimulating effect and may elevate cortisol and prolactin, which researchers should consider in study design.

Q: What distinguishes this blend from the Mod GRF & GHRP-2 blend?

A: While both blends combine a GHRH analog with a GHRP, GHRP-6 has a stronger appetite-stimulating effect and may elevate cortisol and prolactin more than GHRP-2. GHRP-6 also has demonstrated specific wound-healing and neuroprotective properties beyond GH release, making it valuable for tissue repair research.

Q: What purity level can I expect?

A: All batches are tested to ensure ≥99% purity by HPLC analysis. Certificates of Analysis are available upon request.

Q: Is this product for human use?

A: No. Our Mod GRF 1-29 & GHRP-6 blend is manufactured strictly for research use only (RUO). It is not intended for human consumption or clinical applications.

When you need premium mod grf 1-29 ghrp-6 10mg blend for research for your growth hormone axis, tissue repair, neuroprotection, or metabolic studies, choose a manufacturer that prioritizes quality, transparency, and reliability. Liaocheng Yixin Company combines expert peptide synthesis capabilities with rigorous quality control to deliver research materials you can trust.